Insider Transactions in Q1 2025 at Dexcom Inc (DXCM)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 29
2025
|
Kevin R Sayer Chairman, CEO & President |
SELL
Open market or private sale
|
Direct |
33,359
-9.47%
|
$2,868,874
$86.91 P/Share
|
|
Jan 29
2025
|
Jacob Steven Leach EVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,634
-0.97%
|
$226,524
$86.91 P/Share
|
|
Jan 29
2025
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
2,093
-2.74%
|
$179,998
$86.91 P/Share
|
|
Jan 29
2025
|
Matthew Vincent Dolan EVP, Strategy & Corporate Dev |
SELL
Open market or private sale
|
Direct |
1,183
-2.74%
|
$101,738
$86.91 P/Share
|
|
Jan 29
2025
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Open market or private sale
|
Direct |
2,090
-2.44%
|
$179,740
$86.91 P/Share
|
|
Jan 28
2025
|
Kevin R Sayer Chairman, CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
68,503
+16.28%
|
-
|
|
Jan 28
2025
|
Jacob Steven Leach EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,107
+2.55%
|
-
|
|
Jan 28
2025
|
Sadie Stern EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,586
+6.82%
|
-
|
|
Jan 28
2025
|
Matthew Vincent Dolan EVP, Strategy & Corporate Dev |
BUY
Grant, award, or other acquisition
|
Direct |
3,048
+6.59%
|
-
|
|
Jan 28
2025
|
Jereme M Sylvain EVP, Chief Financal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,586
+6.12%
|
-
|